The "Asia-Pacific Highly Potent API Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific highly potent API market is projected to ...
RIVERVIEW, Michigan, Dec. 8, 2020 /PRNewswire/ -- Piramal Pharma Limited's Pharma Solutions business, a leading Contract Development and Manufacturing Organization (CDMO), today announced plans to ...
Global High Potency API CDMOs Market OverviewThe global High Potency API CDMOs market is projected to achieve strong single-digit growth by 2027, driven by a rapid surge in demand for oncology ...
DUBLIN, Jan. 18, 2023 /PRNewswire/ -- The "Small and Midsize Biopharma Perspective on the Highly Potent API Manufacturing Market" report has been added to ResearchAndMarkets.com's offering. Small and ...
EAST RUTHERFORD, N.J., Aug. 08, 2017 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), ...
EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.
DUBLIN--(BUSINESS WIRE)--The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback